Prednisone Treatment for Acute Pseudogout
For acute pseudogout flares, use prednisone 0.5 mg/kg per day (or prednisolone 30-35 mg/day) for 3-5 days, then either stop abruptly or taper over 7-10 days depending on severity.
While the evidence provided focuses primarily on gout rather than pseudogout specifically, corticosteroids are a first-line treatment for both crystal arthropathies, as they share similar inflammatory mechanisms 1, 2.
Recommended Prednisone Regimens
Standard Dosing Options:
Option 1 (Preferred for most cases):
- Prednisone 0.5 mg/kg per day for 5-10 days at full dose, then stop 3
- This approach is simpler and avoids the complexity of tapering for short-course treatment
Option 2 (For severe or polyarticular involvement):
- Prednisone 0.5 mg/kg per day for 2-5 days at full dose, then taper over 7-10 days 3
- The taper reduces risk of rebound flare in more severe cases
Option 3 (Alternative fixed-dose regimen):
- Prednisolone 30-35 mg/day for 3-5 days 1, 2
- This is the EULAR and ACP-recommended dose, shown effective in high-quality evidence for acute crystal arthritis
Key Clinical Considerations:
Timing and Administration:
- Administer in the morning (prior to 9 AM) to minimize HPA axis suppression 4
- Take with food or milk to reduce gastric irritation 4
- Treatment should be initiated as early as possible in the flare 1
Duration Principles:
- For courses ≤10 days at these doses, abrupt discontinuation is generally safe 3
- Tapering is more important for severe polyarticular attacks or if the patient has been on chronic corticosteroids
- Avoid abrupt withdrawal only after long-term therapy 4
Alternative Corticosteroid Routes
If oral therapy is contraindicated or impractical:
- Intramuscular: Triamcinolone acetonide 60 mg IM, followed by oral prednisone as above 3
- Intra-articular: Dose varies by joint size (e.g., triamcinolone acetonide 10 mg for smaller joints) - particularly useful for monoarticular pseudogout 5
Important Caveats
Contraindications to consider:
- Active systemic fungal infections 2
- Uncontrolled diabetes (monitor glucose closely)
- Current infection - must rule out septic arthritis before initiating corticosteroids 5, 6
Common pitfall: Pseudogout can mimic septic arthritis, especially in immunosuppressed patients 6. Always perform arthrocentesis with synovial fluid analysis (looking for rhomboid, weakly positive birefringent calcium pyrophosphate crystals) and culture before starting corticosteroids if infection cannot be clinically excluded.
Adverse effects with short-term use:
- Hyperglycemia, fluid retention, mood changes 2
- These are generally minimal with 5-10 day courses but require monitoring in vulnerable populations
Evidence Quality Note
The guidelines provided are primarily for gout 3, 1, 3, 2, but corticosteroid treatment principles apply equally to pseudogout given the shared inflammatory crystal-induced mechanism 7. Case reports confirm successful treatment of pseudogout with prednisone tapers 8, 9. The 2017 ACP guideline specifically recommends corticosteroids as first-line therapy for acute crystal arthritis due to superior safety profile compared to NSAIDs and lower cost 2.